Loading clinical trials...
Loading clinical trials...
BMT-03: A Phase I Trial of Total Marrow Irradiation in Addition to High Dose Melphalan Conditioning Prior to Autologous Transplant for Patients With Relapsed or Refractory Multiple Myeloma
Conditions
Interventions
Total Marrow Irradiation
Melphalan
+10 more
Locations
1
United States
University of Illinois Cancer Center
Chicago, Illinois, United States
Start Date
January 14, 2014
Primary Completion Date
September 14, 2016
Completion Date
September 14, 2016
Last Updated
November 13, 2024
Lead Sponsor
University of Illinois at Chicago
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions